Navigation Links
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
Date:1/24/2008

>The most common adverse events (greater than or equal to 20%) of Xeloda monotherapy were diarrhea, nausea, stomatitis and hand-foot syndrome. As with any cancer therapy, there is a risk of side effects, and these are usually manageable and reversible with dose modification or interruption.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or http://www.roche.us.

All trademarks used or mentioned in this release are protected by law.


'/>"/>
SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
2. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
3. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
4. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
5. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
6. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
7. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
8. Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
9. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... CLEVELAND, Dec. 15 At today,s regular meeting ... (NYSE: LZ ), the board declared a ... March 10, 2010 to holders of record at the ... About The Lubrizol Corporation ,, The Lubrizol Corporation ... chemical company that produces and supplies technologies that improve ...
(Date:12/15/2009)... Today, Hill-Rom Holdings, Inc. (NYSE: HRC ... strategic and financial initiatives at its Investor Conference ... hosted by Peter H. Soderberg, president and CEO ... following topics: ,, Status of multi-year strategic ... financial updates Smart technologies that interface with ...
(Date:12/15/2009)... Rib-X Pharmaceuticals, Inc., a company focused ... drugs for the treatment of serious multi-drug-resistant infections ... research agreement with Massachusetts General Hospital (MGH). ... collaboration, Dr. David Hooper of MGH will evaluate ... model to determine resistance development and to validate ...
Breaking Medicine Technology:Lubrizol Declares Dividend 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3Smart Post Brings Scrubs 26amp 3B Beyond to Canadian Doorsteps 60656 1Smart Post Brings Scrubs 26amp 3B Beyond to Canadian Doorsteps 60656 2Gastroenterology hepatology societies release report evaluating fellowship training curriculum 60651 1Gastroenterology hepatology societies release report evaluating fellowship training curriculum 60651 2Gastroenterology hepatology societies release report evaluating fellowship training curriculum 60651 3Tags reveal white sharks have neighborhoods in the north Pacific say Stanford researchers 10622 1Tags reveal white sharks have neighborhoods in the north Pacific say Stanford researchers 10622 2Tags reveal white sharks have neighborhoods in the north Pacific say Stanford researchers 10622 3Tags reveal white sharks have neighborhoods in the north Pacific say Stanford researchers 10622 4
... for XIENCE V with No,Late Stent Thrombosis ... Three Years, BARCELONA, Spain, May 22, 2007 ... trial demonstrated no,additional Major Adverse Cardiac Events ... treated with either Abbott's XIENCE(TM) V,Everolimus Eluting ...
... of SEROQUEL XR--, WILMINGTON, Del., May 22, ... analyses from a large-scale,study that investigated the ... a once-daily medicine for the,treatment of schizophrenia ... annual meeting of the American Psychiatric Association,(APA). ...
Other Medicine Technology:Abbott Announces Continued Positive Results with Xience V,Everolimus Eluting Coronary Stent in Spirit Clinical Trials 2Abbott Announces Continued Positive Results with Xience V,Everolimus Eluting Coronary Stent in Spirit Clinical Trials 3Abbott Announces Continued Positive Results with Xience V,Everolimus Eluting Coronary Stent in Spirit Clinical Trials 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
(Date:12/15/2009)... Patient advocate Betsy McCaughey, Ph.D., will be cautioning ... matter whether there,s a public option. The current Senate ... give government authority over how your doctor treats you. ... by shifting billions of dollars from Medicare to handouts ... politicians." ,, Betsy McCaughey is the Founder/Chairman ...
(Date:12/15/2009)... American application activity for individually underwritten life insurance ... MIB Life Index(SM) . Solid growth ... months have lifted year-to-date (YTD) figures from their ... November,s close, -0.1%. "It is clear consumers ... from life insurance," says Stacy Gill, MIB Solutions, ...
(Date:12/15/2009)... A new study links chronic obstructive pulmonary disease, or ... sentinels to activate the body,s immune system. , ... to growing awareness of the immune system,s role in ... than 12 million Americans with wheezing, shortness of breath, ... key if doctors are to find better ways to ...
(Date:12/15/2009)... symptoms will call for help, experts say , , TUESDAY, ... reduced by teaching children how to spot the signs ... a new study shows. , Emergency medical treatment within ... the extent of brain damage and lead to better ... project included 515 sixth graders in Texas who were ...
(Date:12/15/2009)... new employment opportunity for the unemployed or those needing additional income... ... America today. , ... Orlando, FL (PRWEB) December 15, ... agencies, is spreading holiday cheer and good will that is going ... created an opportunity for out of work Americans to get back ...
Breaking Medicine News(10 mins):Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Boosting Kids' Stroke IQ May Save Lives 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3
... less than 2,000 grams (about 4.5 pounds) at birth ... the average teenager to have physical and mental difficulties, ... Archives of Pediatrics & Adolescent Medicine, one of the ... increase the risk for major disabilities such as cerebral ...
... soldiers seriously wounded or injured during combat in Iraq ... the risk for posttraumatic stress disorder (PTSD) and depression, ... The American Journal of Psychiatry, the official journal of ... Thomas A. Grieger, M.D., and colleagues at the Uniformed ...
... controversial crackdown on discount drugs mailed from Canadian pharmacies ... the plans of the federal government, thereby removing the ... ,The Department of Homeland Security, which operates the ... would stop the confiscation of Canadian drugs Monday and ...
... WASH - World Action on Salt and Health has been ... preventing over 2.5 million deaths a year.// ,194 medical ... pressurize food companies into reducing dietary salt intake to prevent ... coincides with a World Health Organisation summit in Paris to ...
... on the field is soon expected to be cut down ... ,NBC4's Dr. Bruce Hensel reported that the new screening program ... Italian athlete teen before he's allowed to play sports. This ... have apparent signs or symptoms. ,Dr. Gaetano Thiene ...
... million grant has been given to a dozen top ... set up a network// that would hasten scientific discoveries ... medical research is done. ,This idea came ... has made it more difficult than ever for scientists ...
Other Medicine News:Health News:Low Birth Weight Babies May Have Mental & Physical Problems 2Health News:US to Lift Ban on Canadian Drug Imports 2Health News:Food Makers Pressurized to Reduce Salt 2Health News:NIH Funds the Development of National Consortium of Universities 2
Weitlaner retractor, blunt....
Daubenspeck sharp curette, 8....
Ring curette, 4 mm 90 angle....
15" overall length, 5" handle....
Medicine Products: